Live Breaking News & Updates on Cholesterol Treatment Trialist

Stay updated with breaking news from Cholesterol treatment trialist. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

High Intensity Statin Therapy Increases Diabetes Risk - Renal and Urology News

High intensity statin therapy was linked to an increased risk for new-onset diabetes, especially among those with high baseline glycemic levels. ....

Cholesterol Treatment Trialist ,

Statins Raise Diabetes Risk, but CV Benefit Outweighs It

Large meta-analysis of individual participant data shows dose-dependent type 2 diabetes increase, but vascular benefit is greater. ....

Christina Reith , Marie Pigeyre , David Preiss , Hertzelc Gerstein , University Of Oxford , Nuffield Department Of Population Health , Mcmaster University , Hamilton Health Sciences , Cholesterol Treatment Trialist , Lancet Diabetes , Nuffield Department , Population Health , Raise Diabetes Risk , Glucose Levels ,

Statins slightly up diabetes risk but cardiovascular benefits remain, finds study

Statin therapy modestly increases diabetes diagnoses but offers substantial cardiovascular benefits, outweighing the slight rise in glycemia, especially in those near diabetes diagnostic thresholds. ....

Roger Ashford , Lancet Diabetes , Image Credit , Cochrane Central Register , Controlled Trials , Cholesterol Treatment Trialist , Medical Dictionary , Regulatory Activities , Cardiovascular Disease , Glycated Hemoglobin ,

Esperion Reports Second Quarter 2023 Financial Results

– Q2 U.S. Net Product Revenue Grew 49% Y/Y to $20.3 Million – – Q2 Retail Prescription Equivalents Grew 26% Y/Y; Q2 New to Brand Prescriptions Grew 28% Q/Q – – Submitted Applications for. ....

United States , Tiffany Aldrich , Alexis Callahan , Sheldon Koenig , Stephenj Nicholls , Kausikk Ray , American Diabetes Association , Exchange Commission , European Medicines Agency , Drug Administration , Endocrine Society Meeting , Journal Of The American Medical Association , European Society Of Cardiology , Product Revenue Grew , Prescription Equivalents Grew , Brand Prescriptions Grew , Submitted Applications , Expanded Indications , Label Changes Expected , Presented New , Bempedoic Acid , Primary Prevention Population , Increasing Addressable Market , Chief Executive Officer , American Medical Association , Supplemental New Drug Applications ,

Statins are unlikely to prevent blood clots

Press release from PLOS Medicine Despite previous studies suggesting the contrary, statins (cholesterol-lowering drugs) may not prevent blood clots (venous thrombo-embolism) in adults, according to a large analysis by international researchers published in this week's PLOS Medicine. In 2009, an additional analysis of data from a randomized controlled trial called the JUPITER trial reported that… ....

United Kingdom , Frits Rosendaal , Kazem Rahimi , Fritsr Rosendaal , Department Of Clinical Epidemiology , University Of Glasgow , University Of Oxford , George Centre For Healthcare Innovation , Research Article , Health Of The Public Research Fellowship , Leiden University Medical Center , Department Of Thrombosis , Oxford Martin School , Biomedical Research Centre , George Centre , Healthcare Innovation , Public Research , Cholesterol Treatment Trialist , Renal Protection , German Diabetes , Dialysis Study , Venous Thromboembolic Events , Unpublished Evidence , Randomised Controlled , Factorv Leiden , Venous Thrombosis ,